Baxter stock

What is the downside in Baxter International's stock price? On average, they expect Baxter International's share price to hit the dollar over the next 12 months. This indicates that the stock has downside potential based on Baxter International's price targets.

What are Wall Street's price targets for Baxter International's stock?

15 Wall Street analysts have released 12-month price predictions for Baxter International stocks. His predictions range from $ to $. On average, they expect Baxter International's stock price to reach $100 over the next 12 months. This suggests that the stock has downside potential.

Who is the CEO of Baxter International?

506 Qualified Employees Baxter International CEO José (Joe) Almeida José (Joe) Almeida has an 85% approval rating among Baxter International employees. Who is one of Baxter International's main competitors?

Who are the competitors of Baxter Inc?

The company was founded in 1931 by Davis Baxter and is headquartered in Deerfield, Illinois. Competitor Name Change % Market Capitalization Medtronic PLC $ Stryker Corp. $ Becton ■■■■■■■■■ & Co. $ DexCom Inc. $ Boston Scientific Corp. $ Fresenius SE & Co.

What is the upside for Baxter International's stock?

Your forecast varies between $ and $. On average, they expect Baxter International's share price to hit $10 over the next 12 months. This indicates a possible rise in the current share price.

What are analysts'target price targets for Baxter International's stock?

13 analysts have posted 12-month price targets for Baxter Internationals stock. Your forecast varies between $ and $. On average, they expect Baxter International's share price to hit $10 over the next 12 months. This indicates a possible rise in the current share price.

What is the net worth of Baxter International?

Baxter International has a market cap in the billions of dollars and generates billions of dollars in annual revenue. A medical device supplier makes billions of dollars in net income (revenue) or dollars each year based on EPS. How many employees does Baxter International have?

How many business segments does Baxter International have?

Analyst Report: Baxter International Inc. Baxter manufactures medical products in seven major industries.

Who are the insiders of Baxter International?

The members of the company who own shares of Baxter International are Albert P.L. Strowken, Andrew Fry, Giuseppe Accoli, James R. Gavin III, Jeanne K. Mason, John D. Forsyth, and Sean Martin. See Baxter International Institutional Ownership Trends. Which Institutional Investors Are Selling Baxter International Shares?

Who owns BaseB Baxter International (BBAY)?

Baxter International stocks are owned by many institutional and individual investors. The main institutional investors are Russell Investments Group Ltd. , Huntington National Bank , DNB Asset Management AS , Beese Fulmer Investment Management Inc. , Jacobs & Co. CA and Trust Co. from Toledo, Carolina North, Ohio ( ).

Is Baxter International's PE ratio higher than its medical peers?

Baxter International's P/E is , meaning it trades at a higher P/E than the average P/E of the medical industry around Baxter International, which has a P/E.

Does the January share price reflect Baxter's intrinsic value?

Baxter International Inc. (NYSE: BAX) January Price Its True Value? Today, they estimate the intrinsic value of a stock by taking a company's expected future cash flows and discounting them to their present value. One way to do this is to use a Discounted Cash Flow (DCF) model.

What is the B Baxter stock price prediction for 2021-12-28?

Trading Baxter International Inc. is 20211228 US dollars. Based on their forecast, long term growth is expected, BAX share price forecast for 20261222 is USD.

What are the price targets for Baxter International's stock?

On average, they expect Baxter International's share price to hit the dollar over the next 12 months. This indicates a possible rise in the current share price. Check out analyst price targets for the top rated stocks of Baxter International or Wall Street.

Does Baxter International have a good return on equity?

On the surface, Baxter International appears to have a decent return on capital. Especially when compared to the industry average of 9.7%, the company's ROE looks quite impressive. Needless to say, they are very surprised to see Baxter International's net revenues have fallen 26% over the past five years.

Who is the ceo of baxter international company

José E. Almeida is the president and CEO of Baxter International. Baxter International's top executives include José E. Almeida and 35 others .

Who are the key executives of Baxter International?

José E. Almeida is the president and CEO of Baxter Internationals. Baxter International's top executives include José E. Almeida and 37 others. José E. Almeida Senior Vice President and President of US and Global Business Units.

What is the corporate address for Baxter Corporation?

Accessed Feb. 2, 2011. Business Address: One Baxter Parkway Deerfield, IL 600154625. ^ a b Form 10K, 2013 (PDF). Archived from the original (PDF) on July 3, 2014. Retrieved on July 14, 2014.

What is the history of the Company B Baxter?

Baxter International was founded in 1931 by Donald Baxter, a Los Angeles physician, as a manufacturer and distributor of intravenous therapy solutions. Recognizing the need for products closer to the Midwest, the company opened a manufacturing facility in Glenview, Illinois, in 1933.

Is Baxa owned by Baxter?

Baxter acquired medical technology company Baxa on November 10, 2011. In 2011, Hikma Pharmaceuticals PLC completed the acquisition of the generic injectables (MultiSource Injectables or MSI) business of Baxter Healthcare Corporations in the United States. In July 2013, the EU competition authorities approved Baxters' offer to buy Gambro in Sweden.

Who is the ceo of baxter international stock

Source: Shutterstock Baxter International Inc. (NYSE:BAX) has performed well enough and CEO Joe Almeida has done a good job driving the company in the right direction.

Is Baxter International's (Bax) earnings growing or shrinking?

So in the next step, they compared Baxter International's performance to that of the industry and were disappointed to find that industry revenues had increased 13% over the same period, while the company's revenues had fallen.

Why did QuickB Baxter International’s stock price rise under Almeida?

Baxter International under Almeida's leadership has made significant progress as a result of Almeida's changes.

What kind of company is Baxter International?

Baxter International Inc. is an American Fortune 500 healthcare company headquartered in Deerfield, Illinois. The company mainly specializes in products for the treatment of haemophilia, kidney disease, immune disorders and other chronic and acute diseases. In 2017, the company's revenue was $10.

Who is the president of Baxter International Foundation?

Senior Vice President of Global Communications and President of the International Baxter Foundation Christiano Franzi Senior Vice President and President of EMEA Andrew (Andy) Fry Senior Vice President and President of APAC.

What does the Medical Device Company B Baxter do?

Baxter International develops, manufactures and markets products for people with haemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute conditions. The company operates in three segments: Life Sciences, Drug Administration and Renal.

Who are Baxter International's (Bax) competitors?

Baxter International's main competitors are: B. Braun, Grifols, Fresenius Medical Care North A, Fresenius Which companies has Baxter International acquired? Baxter International has acquired the following companies: FDS Amplicare, EHT Machine Tools, CDH Consilio, Medicraft HillRom Australia.

What industry is Baxter International in?

Baxter International's businesses include: medical devices and equipment, drug manufacturing, manufacturing and research. Who are Baxter International's main competitors? Baxter International's main competitors are: B. Braun, Grifols, Fresenius Medical Care North A, Fresenius.

Why SWOT analysis for Baxter International?

SWOT analysis is a proven management system that allows brands like Baxter International to compare their business and performance with that of the competition. Baxter International is one of the leading brands in the pharmaceutical and health sector.

Who are competitors of Baxter International?

Baxter International's competitors are Abbott, Becton ■■■■■■■■■ and Medtronic. Where is Baxter International's headquarters? Baxter International is headquartered at 1 Baxter Pkwy, Deerfield.

How many employees does Baxter have in the US?

Baxter International has 50,000 employees at 75 locations and will generate annual revenues of $1 billion in fiscal 2020. Learn more about Baxter International, including locations, competitors, revenue, finance, executives, subsidiaries and more at Craft.

Who uses Baxter's products?

The products are used by hospitals, renal dialysis centers, nursing homes, rehabilitation centers, doctors' surgeries and patients at home under the supervision of a physician. Baxter Internationals reported $1 billion in revenue for fiscal year 2020, up from the same period last year.

What are Baxter International's key business segments?

Baxter International's current market cap is $39 billion. Baxter International Sales Breakdown by Business Line: Emergency Medicine, Advanced Surgery, Clinical Nutrition, Pharmaceuticals, Drug Delivery, Kidney Care, and Others .

Who are the competitors of baxter inc 2020

Baxter International's main competitors are Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, ■■■■■■■■■ and (BDX), Boston Scientific (BSX), DexCom (DXCM ). † ), IDEXX Laboratories (IDXX), and ResMed (RMD). All these companies are part of the medical device industry.

Who are the competitors of baxter inc products

Companies in the medical device subsector are considered alternatives and competitors to Baxter International, including Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, ■■■■■■■■■ and (BDX) and Boston. Scientist (BSX).

Who are Baxter International's competitors?

These are Baxter International's 3 main competitors: 1 Johnson & Johnson 2 Fresenius Medical Care AG & Co 3 Grifols,.

What is the difference between B Baxter and Johnson&Johnson?

Baxter International is a supplier of critical care, nutritional, renal, hospital and surgical products. Johnson & Johnson is a global holding company engaged in the research and development, manufacture and sale of a range of health care products.

Who are Abbott's main competitors?

Abbott's competitors are removing everything. Abbott's main competitors are AbbVie, BioRad, Philips, Danaher, Pfizer, Roche, Amgen, Johnson & Johnson, Novo Nordisk and Bruker Corporation.

How much money does Baxter International make?

Baxter Internationals reported $1 billion in revenue for fiscal year 2020, up from the same period last year. Baxter International's current market cap is $39 billion.

How much did Baxter return to shareholders in 2020?

In 2020, they returned approximately $1 billion to shareholders in dividends and share repurchases and used approximately $500 million in inorganic investments to drive future growth. Baxter continues to achieve significant strategic results in its mission to save and preserve lives.

Where is the headquarters of Baxter International located?

Baxter International is headquartered at 1 Baxter Pkwy, Deerfield. Where are Baxter International's offices located? Baxter International has offices in Deerfield, Marion, Opelika, Round Lake and 66 other locations. How many offices does Baxter International have?

Who are the competitors of baxter inc llc

Baxter International's main competitors are Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, ■■■■■■■■■ and (BDX), Boston Scientific (BSX), DexCom (DXCM ). † ), IDEXX Laboratories (IDXX), and ResMed (RMD).

What is the ticker symbol for Edwards Lifesciences?

Edwards Lifesciences is listed on the New York Stock Exchange (NYSE) under the symbol EW. Who are the major shareholders of Edwards Lifesciences? The shares of Edwards Lifesciences are held by a variety of private and institutional investors.

What is the downside in Edwards Lifesciences'stock price?

On average, they expect the price of Edwards Lifesciences stock to reach $1 in the next year. This indicates that the stock has downside potential relative to analysts' price targets for Edwards Lifesciences.

Is ededwards Lifesciences (Edw) stock a buy or sell?

Edwards Lifesciences received a buying consensus rating. The average business rating is , based on 15 buy reviews, 4 hold reviews, and no sales reviews. Based on analysts' $$ price target, Edwards Lifesciences predicts an increase from the current $$ price.

What are analysts'price targets for Edwards Lifesciences stock?

20 stock analysts have posted 12-month price targets for Edwards Lifesciences stock. His predictions range from $ to $. On average, they expect the price of Edwards Lifesciences stock to reach $1 in the next year.

Is Baxter International’s stock outperforming its competitors despite losses?

Share of Baxter International Inc. outperforms competitors despite losses Jan 14. 2022 4:40 a.m. ET from MarketWatch Automation. Share of Baxter International Inc. outperforms competitors despite losses Jan 13. 2022 4:39 a.m. ET from MarketWatch Automation.

When is Baxter's Q4 earnings release date?

DEARFIELD, IL, Jan. 6, 2022 - Baxter International Inc. (NYSE:BAX), the world's leading medical technology company, will host a conference call on Thursday, February 17, 2022 at 7:30 a.m. ET. m. on Central Channel to announce fourth quarter 2021 financial results at a time of discussion.

What does Bax stand for?

BUCK | All Baxter International Inc. stock market news. from market watch. View real-time stock prices and quotes for a complete financial overview. BUCK | All Baxter International Inc. stock market news. from market watch.

What is the price targets for Edwards Lifesciences stock?

Based on data from 14 analysts who have provided 12-month price targets for the past 3 months, Edwards Lifesciences has set an average price target in USD with a high of $ and a low of $.

Who owns ededwards Lifesciences'stock?

The shares of Edwards Lifesciences are held by a variety of private and institutional investors.

When is Edwards Lifesciences'next quarterly earnings announcement?

Edwards Lifesciences is expected to publish its next quarterly results on Wednesday, January 26, 2022. See Edwards Lifesciences earnings forecast. What was Edwards Lifesciences revenue last quarter? Edwards Life Sciences Co. (NYSE:EW) released its results on Wednesday, October 27.

What is Edwards Lifesciences Corporation known for?

No titles available Edwards Lifesciences Corp. Edwards Life Science Corp. is committed to patient-centered medical innovations for cardiac monitoring and critical care. The products are divided into three areas: transcatheter heart valves, surgical structural heart and intensive care.

What are analysts' price targets for Shire stock?

4 Equity Research analysts have published one-year target prices for Shires stock. Your prediction is between $ and $. On average, they expect Shires' stock price to hit $100 next year. See analysts' price targets for Shire.

How much is a share of Shire worth?

SHPG shares can currently be bought for about $1. How much money does Shire make? Shire has a market cap in the billions of dollars and annual sales in the billions of dollars.

What is Shire plc's (shpg) Q1 Earnings Report?

Shire plc (NASDAQ:SHPG) released quarterly earnings on Thursday, April 26. The biopharma company reported earnings per share (EPS) in dollars for the quarter, beating the consensus estimate on a $-for-$ basis. The biopharmaceutical company reported revenue of $1 billion in the quarter.

What is shareshire plc?

SHIRE PLC is a global biotechnology group dedicated to helping people with rare and other special diseases.

What is the ticker symbol for Baxter International?

Baxter International is listed on the New York Stock Exchange (NYSE) under the symbol BAX. Baxter International announced a quarterly dividend on Tuesday, July 16.

Baxter stock split

Baxter International (BAX) has 4 divisions in the Baxter International Stock Division database. The first split of BAX took place on November 18, 1983. This was a 2-for-1 split, meaning that the shareholder now owned 2 shares for every BAX share he owned before the split.

What happens when a stock splits?

A stock split is when a company divides its shares into smaller parts while retaining the entire share capital.

When are stocks split?

A stock split occurs when a company divides the price of one share by a factor related, for example, to the number of additional shares issued. B. 2 to 1. Regardless of the ratio, the share price will fall and the number of outstanding shares will increase.

How does a stock split work?

A stock split is what happens when a company increases the number of publicly traded shares in the market. When a stock split is triggered, the stock price falls, but the total value remains the same as the volume of the stock increases proportionally.

What are split shares?

A stock split occurs when a company increases or decreases the number of shares issued by the company. A stock split can also be called a stock split or stock consolidation. Companies may choose to split stocks for a variety of reasons, including to control share value or increase/decrease the number of shares outstanding.